Government, Industry, Non-Profit, Academic Partners
Partnerships are the heart of our Wellstone MD CRC. Collaborators and expert consultants support the cores and projects are experts in their respective scientific, clinical and service areas.
Patient Advocacy Partners
Daniel Paul Perez, A.B., Chief Science Officer and Co-founder, FSH Society, Inc., UMMS, Worcester, Massachusetts. As an FSHD patient advocate, Mr. Perez has a leadership role in the Center and in Core A specifically to implement communications strategies, help to manage the Center Website, organize the Patient-Researcher Meeting and International Workshops, and work with patients and families to provide education and support for their participation in the Core C biopsy program. The FSH Society and the Center cost share to organize these meetings.
Natalie Moss, Founder and Chairman of the Australia-based FSHD Global Research Foundation, is a member of the Wellstone Center Advisory Committee.
Dr. Jennifer Chen, Ph.D., Research Associate, Wellstone Muscular Dystrophy Program at UMMS. Dr. Chen is an expert in muscle stem cell biology. She oversees the development of the FSHD cell and DNA repository in Core C and collaborates in the biomarker discovery and therapeutic development research programs of Projects 2 and 3.
Dr. Michael Brehm, M.D., Associate Professor in the department of Molecular Medicine at UMMS. Specializes in Xenograft modeling of the innate immunity response to FSHD disease pathology.
Daniel MacArthur, Ph.D., Co-director of Medical and Population Genetics Program at the Broad Institute of MIT and Harvard. Specializing in FSHD transcriptomes.
Beryl Cummings, Graduate student from the Biomedical and Biological Sciences Program at Harvard. Ms. Cummings is a member of Dr. MacArthur's lab and also specializes in FSHD transcriptomes.
Anastasia Khvorova, Ph.D., Professor in the RNA Therapeutics Institute at UMass Medical School, specializing in the development of oglionucleotide therapeutics.
Jonathan Watts, Ph.D., Associate Professor in the RNA Therapeutics Institute at UMass Medical School, specializing in nucleic acids chemical biology.
Genea, iPSC myogenesis and small molecule FSH therapeutic development
New York Genome Center, Genome and methylome sequencing.
Center Consultants and Services
Dr. Steven Moore, M.D., Ph.D., Professor of Pathology, University of Iowa School of Medicine and the Iowa Wellstone. Dr. Moore and the Iowa Diagnostics Lab is responsible for FSHD genotyping blood and muscle samples for patients participating in Center research.